Security key
92686J106
Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 71,856,661
- Total 13F value
- $2,527,921,428
- Share change
- -959,273
- Put/Call ratio
- 44%
- SEC-reported price per share
- $35.18
- Number of holders
- 416
- Value change
- -$5,880,372
- Number of buys
- 199
- Number of sells
- 176
- Shares outstanding
- 115,694,154
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2025
Institutions
416
Top holders
10
VKTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Viking Therapeutics, Inc. SEC filings
Viking Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92686J106
Recent filing periods:
Ownership snapshot
Top reported holders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F
13D/G
Lead comparable stake: 5.1%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
FMR LLC
5.1%
BlackRock, Inc.
4.5%
VANGUARD GROUP INC
8.6%
STATE STREET CORP
3.9%
MORGAN STANLEY
3.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
5.1%
from 13D/G
|
$152,162,529
5,790,051 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
4.5%
from 13D/G
|
$147,067,246
5,596,166 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
8.6%
|
$262,776,531
9,999,107 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
3.9%
|
$118,623,505
4,513,832 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
3.2%
|
$98,001,218
3,729,117 shares
|
— | 30 Sep 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.2%
|
$67,725,865
2,577,087 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
416
Shares
71,856,661
Rows available
416
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
366
Q4 2025 holders
416
Holder diff
50
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend